Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bush Jennifer, holds the title of COO, CLO, Compliance Officer at Artiva Biotherapeutics, Inc..
On 2026-11-17, the insider transacted 19,217 shares.The shares were transacted at a weighted average price of $3.91 per share, resulting in a total market-relevant value of $75K.
Bush Jennifer (COO, CLO, Compliance Officer) sold $75K of $ARTV
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.